Stone House Investment Management »

Rapport Therapeutics shares owned by Stone House Investment Management

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Stone House Investment Management from 13F filings

Historical chart of Stone House Investment Management investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Stone House Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Stone House Investment Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $8.8k 211 41.67

More positions owned by Stone House Investment Management

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Univrsl Usd (IUSB)
Spdr Series Trust St Str P500etf (SPYM)
Ishares Tr S&p 500 Grwt Etf (IVW)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Ishares Tr S&p 500 Val Etf (IVE)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Ishares Tr Core Msci Total (IXUS)
Procter & Gamble Company (PG)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Eafe Grwth Etf (EFG)
Blackrock Etf Trust Isha I In Te Etf (BAI)
Fidelity Covington Trust Enhanced Intl (FENI)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Msci Usa Mmentm (MTUM)

View all positions for Stone House Investment Management

Top funds holding Rapport Therapeutics

FMR
TRV GP V
Arch Venture Corp
Capital Research and Management Company - Division 3
Goldman Sachs Group
BlackRock
Cormorant Asset Management
Sofinnova Ventures
Johnson & Johnson
Polar Capital Holdings
Baker Bros. Advisors
Vanguard Capital Management
Trv Gp Vi
T. Rowe Price Associates
Geode Capital Management

View all funds holding Rapport Therapeutics